Mallinckrodt Pays $35M To Settle Federal Investigations Of Controlled Substances

(July 12, 2017, 10:44 AM EDT) -- WASHINGTON, D.C. — Opioid drug maker Mallinckrodt LLC has agreed to pay $35 million to settle three federal investigations into the company’s alleged violations of the Controlled Substances Act, the U.S. Justice Department announced July 11 in a press release....

Related Sections